Quality

The focus of quality improvement in healthcare is to bolster performance and processes related to diagnostic and therapeutic procedures. Leaders in this space also ensure the proper selection of imaging exams and procedures, and monitor the safety of services, among other duties. Reimbursement programs such as the Merit-based Incentive Payment System (MIPS) utilize financial incentives to improve quality. This also includes setting and maintaining care quality initiatives, such as the requirements set by the Joint Commission.

Out of service: Donated medical devices in the developing world

Nahid Bhadelia, an infectious disease physician at Boston Medical Center and the director of Infection Control at National Emerging Infectious Diseases Laboratory, penned a commentary about donated medical devices in the developing world on NPR.com.

Using patient experience scores to determine payment works within value-based purchasing

Using patient experience scores from the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) is working as intended within CMS’s Value-Based Purchasing (VBP) program, according to a study published in the journal Health Affairs.

Which states have the best and worst healthcare systems?

Minnesota was ranked no. 1, while Alaska finished at the bottom, in a state-by-state ranking of healthcare quality and cost-effectiveness by personal finance site WalletHub.

Low-level trauma patients see greatest mortality risk weeks after injury

Patients who suffered low-level traumatic injuries were at greatest risk of dying two to three weeks after being injured, according to study of European patients.

How hospitals are responding to costly intestinal bacteria

Clostridium difficile, commonly abbreviated as C. diff, infected nearly a half-million people in 2011, with 65 percent of those cases related to a hospital stay. Athena's Peter Barnes looked at several new treatments hospitals are developing either to prevent the infections in the first place or fight them once antibiotics stop working.

CMS spent more in ACO bonuses than program saved in 2015

While CMS touted the latest quality and financial reports from Medicare accountable care organizations (ACO) as positives, its data said the agency spent $217 million more in bonuses to ACOs than what the programs are projected to have saved.

Hospitals rethinking approach to medical errors

Instead of the “deny-and-defend” strategy typically employed when a medical procedure goes wrong, more hospitals and physicians are getting used to the idea of a more open, honest discussion about adverse events.

Dueling JAMA articles judge whether ACOs have been successful

In response to the view of two Duke University professors who claimed accountable care organizations (ACOs) “have failed to produce needed efficiencies,” another JAMA Viewpoints article defends the ACO model and encourages CMS not to abandon it.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.